An oral drug delivery system with programmed drug release and imaging properties for orthotopic colon cancer therapy-Reference-Cited by-同舟云学术

An oral drug delivery system with programmed drug release and imaging properties for orthotopic colon cancer therapy

Published:2019 Issue:34 Volume:11 Page:15958-15970
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Song Qingling¹²³⁴⁵,Jia Jiajia¹²³⁴⁵,Niu Xiuxiu¹²³⁴⁵,Zheng Cuixia¹²³⁴⁵,Zhao Hongjuan¹²³⁴⁵,Sun Lingling¹²³⁴⁵,Zhang Hongling¹²³⁴⁵,Wang Lei¹²³⁴⁵,Zhang Zhenzhong¹²³⁴⁵^ORCID,Zhang Yun¹²³⁴⁵^ORCID

Affiliation:

1. School of Pharmaceutical Sciences

2. Zhengzhou University

3. Zhengzhou 450001

4. China

5. Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases

Abstract

Oral drug delivery systems (ODDSs) have attracted considerable attention in relation to orthotopic colon cancer therapy due to certain popular advantages.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2019/NR/C9NR03802G

Reference40 articles.

1. A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer

2. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

3. Silencing of Intestinal Glycoprotein CD98 by Orally Targeted Nanoparticles Enhances Chemosensitization of Colon Cancer